News

In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct trials transplanting genetically-modifie ...
New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...
In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...
Key takeawaysUCLA researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as ...
Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...
Carla Nester, MD, MSA, FASN, is coinvestigator for the ongoing APPEAR-C3G trial (NCT04817618), data from which were used to ...
In this video, Girish N Nadkarni, MD, a professor of medicine at the Icahn School of Medicine at Mount Sinai, discusses recent advancements in chronic kidney disease care.
March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...